1
Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:February 20, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:February 20, 2017Completed
Condition(s):Type 2 DiabetesLast Updated:August 9, 2011Unknown status
Condition(s):Diabetes Mellitus, Type 2Last Updated:March 14, 2016Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:November 3, 2016Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:April 19, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.